Metabolon: The Leader in Metabolomics
Metabolon is a pioneer and leader in metabolomics - an integrative, powerful technology for assessing health. Our proprietary platforms and informatics systems are delivering biomarker discoveries, innovative diagnostic tests, breakthroughs in precision medicine, and robust partnerships in genomics-based health initiatives.
We are using our technology to advance precision medicine through novel metabolomics-based clinical diagnostic tests that may improve early detection of diseases. We also offer scalable, customizable metabolomics research services to academic and commercial investigators in every area of the life sciences.
Innovation Powered by Proprietary Technology
Our experienced team of Ph.D. scientists, biostatisticians and informaticists has created the industry’s most comprehensive metabolomics platform (DiscoveryHD4™). We also offer a suite of focused panels and customizable targeted assays, which are useful for validating hypotheses or exploring a particular metabolite or metabolite class.
Metabolon has developed novel clinical tests derived from our metabolomics expertise. Our laboratory-developed tests (LDTs) include META IMD™ (a test for assessing inherited metabolic disorders), QUANTOSE™ IR (a blood test for gauging early-stage insulin resistance) and QUANTOSE™ IGT (a blood test that measures impaired glucose tolerance). Our growing precision medicine pipeline is focused on obesity-related diseases, such as chronic kidney disease and NASH, and providing global metabolic insight that promotes wellness.
Unmatched Experience & Expertise
Founded in 2000, Metabolon has served over 700 clients, and we have formed strategic partnerships with several major research institutions, as well as many pharmaceutical, agricultural, nutrition and consumer goods companies.
We currently have about 160 highly qualified employees, including more than 40 Ph.D.s from diverse backgrounds in molecular biology and biochemistry, and an experienced staff of statisticians, bioinformaticians, chemists, software developers and engineers. With over 5,000 completed projects behind us, our institutional knowledge is unmatched in the industry.
In addition, the staff at Metabolon has written and contributed to over 600 peer-reviewed journal publications, including numerous articles in Cell, Nature and Science. Our publications and case studies are available in the Resources section.